secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0000950170-23-033405
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Core Laboratories terminates $60M ATM program; no shares sold under agreement
-----------------------------------------------------------------------------

- Terminated Equity Distribution Agreement dated June 9, 2022 with Wells Fargo and BofA.
- Program authorized up to $60M in 'at the market' common stock offerings; zero shares were ever sold.
- Termination effective July 17, 2023; no future sales under this program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017023033405/0000950170-23-033405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017023033405/clb-20230717.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-033405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer